Skip to main content
Macrogen, Inc. logo

Macrogen, Inc. — Investor Relations & Filings

Ticker · 038290 ISIN · KR7038290003 KO Professional, scientific and technical activities
Open in API
Filings indexed 352 across all filing types
Latest filing 2021-03-04 Notice of Dividend Amou…
Country KR South Korea
Listing KO 038290

About Macrogen, Inc.

https://www.macrogen.com/en/main

Macrogen, Inc. is a biotechnology company specializing in precision medicine and genomic analysis. It provides a comprehensive suite of services, including Next-Generation Sequencing (NGS), Sanger sequencing, and spatial transcriptome analysis, to a global client base. The company's core activities are focused on three key areas: Research and Data Analysis, offering fast and accurate genomic services to the scientific community; Clinical Diagnostics, advancing disease prediction through the integration of genomic and medical big data; and Personal Healthcare, providing genetic tests for wellness, nutrition, and disease risk assessment. By combining its extensive genomic expertise with big data and AI, Macrogen aims to deliver hyper-personalized healthcare solutions and innovate in the field of future medicine.

Recent filings

Filing Released Lang Actions
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement regarding the decision to pay cash dividends, detailing the dividend amount per share, total dividend amount, record date, and the approval process by the board of directors. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2021-03-04 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the scheduling of a General Meeting of Shareholders on a 'concentrated date'. It explains the company's inability to avoid this date due to audit and reporting obligations. Since this is a specific regulatory disclosure regarding meeting logistics and does not fit into the specific categories for AGM presentations, proxy statements, or voting results, it is classified as a general regulatory filing.
2021-03-04 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Macrogen) announcing a significant change in financial results (30% or more change in revenue or profit structure). This is a standard disclosure requirement for listed companies in Korea to report preliminary financial performance before the final audit is completed. Since it provides key financial highlights and reasons for the change rather than being a full annual report or a simple announcement of a report's availability, it falls under the 'Earnings Release' category as it serves as the initial announcement of financial results. FY 2020
2021-02-16 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Macrogen regarding a correction to a previously submitted 'Stock Option Grant' report (주식매수선택권 부여에 관한 신고). It details specific changes to the number of grantees and the number of shares granted due to employee resignations. Since this is a formal regulatory disclosure regarding capital structure and equity compensation, and it does not fit into specific categories like 'Director's Dealing' (which is for individual insider trades) or 'Share Issue' (which is for new capital issuance), it is best classified as a general Regulatory Filing (RNS).
2021-02-16 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically a '정정신고' (Amendment Report). It details changes to stock option grants, including the number of shares and the list of recipients. This type of disclosure regarding equity compensation and capital structure changes falls under the category of Regulatory Filings (RNS) as it is a specific corporate disclosure required by the financial authorities (Financial Services Commission/Korea Exchange).
2021-02-16 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Acquisition Status by Trust Agreement' (신탁계약등에의한취득상황보고서) filed by Macrogen. It details the company's purchase of its own shares through a trust contract with Mirae Asset Daewoo. This type of filing specifically reports the company's activity in buying back its own shares, which falls under the 'Transaction in Own Shares' category.
2021-02-03 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.